Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

MTF Biologics and Kolosis BIO introduce Summit Matrix™, expanding solutions for orthopedic and spinal surgeries

Putty. Summit Matrix features NanoLift’s nanocrystalline, plate-like surface, which supports cell activity to promote bone formation. Its hydroxycarbanoapatite composition closely mimics natural bone mineral, enabling optimal resorption and...

First National Campaign Launched by Trauma Intervention Programs (TIP)

clients throughout the West Coast and is committed to compassionate advocacy and aggressive representation. For more information please visit, www.avrek-law-firm.com

Lansinoh® Launched NaturalWave® Double Electric Breast Pump Featuring Exclusive Flutter Technology for Increased Milk Output

16, 2026. The pump will be available through DME (Durable Medical Equipment) providers as an upgrade option. For more information about Lansinoh's full portfolio of products, visit www.lansinoh.com or follow @LansinohUSA on Instagram, TikTok,...

Align Technology Supports Children and Teens With 30 Invisalign® Treatments via Smiles4Canada Program

patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for...

Alamar Biosciences announces the launch of the NULISAqpcr™ AD 5-plex assay, advancing blood-based biomarker detection for Alzheimer’s disease research

from a single blood or plasma sample. The NULISAqpcr AD 5-plex Assay consolidates key biomarkers into a single multiplexed format, delivering unmatched sensitivity, specificity, and ease of use. By incorporating BD-pTau217, Aβ42, NfL, and GFAP, the...

Ad Hoc Analyses Indicate Enhanced Survival Outcomes with VYLOY™ (zolbetuximab) Combined with Chemotherapy When Common Adverse Events Are Properly Managed

is a global life sciences company committed to turning innovative science into value for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our...

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

expertise to support member compliance and improve awareness of existing pharmaceutical disposal options. For more information please visit, www.PPSWG.org.

Clover Begins Phase 2 Clinical Evaluation of a Combination Respiratory Vaccine Targeting RSV, hMPV, and ± PIV3

F (PreF)-Trimer subunit vaccine antigens utilizing Clover's validated Trimer-Tag vaccine technology platform. "The initiation of this Phase 2 trial for our respiratory combination vaccine candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV +...

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

human plasma-derived fibrinogen concentrate approved for AFD in the U.S. The product's lyophilized powder formulation allows for rapid reconstitution at the point of care, offering a more consistent and targeted alternative to cryoprecipitate,...

Ark Biopharmaceutical Granted China Marketing Authorization for Aizhida in ADHD Treatment

the treatment of ADHD. Each once-daily capsule contains serdexmethylphenidate (SDX), a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate (d-MPH) in a fixed ratio designed to provide both rapid and extended...

Novotech Appoints Anand Tharmaratnam as Chief Executive Officer

in Singapore. The appointment follows a thoughtful and considered process. In early September 2025, Novotech’s former CEO Dr. John Moller informed employees of his intention to step down from the position at the end of last year, after nine years...

Coya Therapeutics Announces Results from an Investigator-Initiated Study Showing Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients Treated with Low-Dose IL-2 and CTLA4-Ig

modalities aimed at restoring the anti-inflammatory and immunomodulatory functions of Tregs. Coya’s therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. For more information please visit...

RoslinCT and BOOST Pharma Form Strategic Manufacturing Partnership to Advance Cell Therapy for Osteogenesis Imperfecta

Institutet, a world leader in cell therapy research. Its lead program, BT-101, is a novel MSC-based therapy with high bone-forming capability. Preclinical and clinical studies have demonstrated promising results, including improved bone formation,...

Orum Therapeutics Names Chad May Chief Scientific Officer to Advance Degrader-Antibody Conjugate Programs

a track record of advancing antibody drug conjugates (ADCs), T-cell engagers, and other next-generation therapeutic platforms from concept to clinical evaluation. “Chad has repeatedly demonstrated an ability to take bold scientific concepts and...

In Europe, Samsung Bioepis begins the commercialization of BYOOVIZ®, a biosimilar to Lucentis (Ranibizumab)

areas, including immunology, oncology, ophthalmology, hematology, nephrology, neurology, and endocrinology. For more information, please visit www.samsungbioepis.com

Peer-reviewed validation of a 60-channel closed-loop neurostimulation brain implant is published by Nia Therapeutics

Preclinical Validation in Freely Moving Large Animals In a chronic study of three sheep, the SNS demonstrated stable performance across core functions: Neural-state decoding. Machine-learning classifiers distinguished movement from stillness with...

Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium

sepsis is the most common cause of in-hospital deaths, costing over $62 billion annually in the USA alone. For more information please visit, www.sepsis.com

Sapio Sciences Collaborates with the Wellcome Sanger Institute on Transforming Digital Laboratories

Sapio Sciences, the science-awareTM AI lab informatics platform, announced that the Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s ambitious lab transformation program. The...

Medra Raises $52 Million in Series A Funding to Build Physical AI Scientists

Medra, the company developing the first platform for Physical AI Scientists, announced a $52 million Series A financing led by Human Capital, with participation from existing investors Lux Capital, Neo, and NFDG, alongside new investors Catalio...

Voranigo® (vorasidenib) from Servier has received multiple regional Prix Galien Awards

Kingdom, in Japan and Europe (27 countries of the European Union as well as Iceland, Liechtenstein and Norway). For more information please visit, www.servier.com